Dennis Podlesak is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 191,763 shares of SNDX, which is worth approximately $2.57 Million. The most recent transaction as insider was on Feb 05, 2025, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 192K
35.27% 3M change
35.27% 12M change
Total Value Held $2.57 Million

Dennis Podlesak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2025
BUY
Grant, award, or other acquisition
-
50,000 Added 20.68%
191,763 Common Stock
Feb 07 2024
BUY
Grant, award, or other acquisition
-
34,000 Added 19.34%
141,763 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
32,000 Added 22.9%
107,763 Common Stock
Sep 16 2022
SELL
Open market or private sale
$280,574 $23.43 p/Share
11,975 Reduced 13.65%
75,763 Common Stock
Sep 16 2022
BUY
Exercise of conversion of derivative security
$75,922 $6.34 p/Share
11,975 Added 12.7%
82,319 Common Stock
Sep 15 2022
SELL
Open market or private sale
$1,617,528 $24.2 p/Share
66,840 Reduced 46.87%
75,763 Common Stock
Sep 15 2022
BUY
Exercise of conversion of derivative security
$422,429 $6.32 p/Share
66,840 Added 31.91%
142,603 Common Stock
Feb 02 2022
BUY
Grant, award, or other acquisition
-
32,000 Added 29.69%
75,763 Common Stock
Oct 05 2021
BUY
Other acquisition or disposition
-
463 Added 1.05%
43,763 Common Stock
Apr 22 2021
BUY
Open market or private purchase
$197,074 $14.11 p/Share
13,967 Added 24.39%
43,300 Common Stock
Feb 03 2021
BUY
Grant, award, or other acquisition
-
29,333 Added 50.0%
29,333 Common Stock
DP

Dennis Podlesak

Waltham, MA

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if
Any

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Syndax Pharmaceuticals Inc

Track Activities on SNDX